Therapeutic Plasma Exchange Market Size, Share, Industry Trends and Forecast to 2033
This report covers a comprehensive analysis of the Therapeutic Plasma Exchange (TPE) market from 2023 to 2033, providing insights into market sizes, growth forecasts, industry trends, segmentation, and a regional breakdown to indicate market dynamics across various geographies.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $5.60 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $11.01 Billion |
| Top Companies | Terumo BCT, Fresenius Kabi, Haemonetics Corporation, Grifols |
| Last Modified Date | 15 Nov 2024 |
Therapeutic Plasma Exchange Market Report (2023 - 2033)
Therapeutic Plasma Exchange Market Overview
What is the Market Size & CAGR of Therapeutic Plasma Exchange market in 2023?
Therapeutic Plasma Exchange Industry Analysis
Therapeutic Plasma Exchange Market Segmentation and Scope
Request a custom research report for industry.
Therapeutic Plasma Exchange Market Analysis Report by Region
Europe Therapeutic Plasma Exchange Market Report:
The European market is forecasted to grow from $1.52 billion in 2023 to $2.98 billion by 2033. The growth in this region is propelled by increasing prevalence of autoimmune diseases and the presence of key market players.Asia Pacific Therapeutic Plasma Exchange Market Report:
In the Asia Pacific region, the Therapeutic Plasma Exchange market is projected to grow from $1.07 billion in 2023 to $2.10 billion by 2033, driven by increasing disease prevalence, enhanced healthcare infrastructure, and growing collaborations among market players.North America Therapeutic Plasma Exchange Market Report:
North America leads the market with a valuation of $2.10 billion in 2023, projected to reach $4.13 billion by 2033. This market dominance is supported by established healthcare systems, advanced medical technology, and significant healthcare expenditures.South America Therapeutic Plasma Exchange Market Report:
The South American market is expected to expand from $0.37 billion in 2023 to $0.73 billion in 2033. This growth is attributed to improving healthcare access, rising awareness about plasma therapies, and increasing investments in healthcare.Middle East & Africa Therapeutic Plasma Exchange Market Report:
The Middle East and Africa market is anticipated to grow from $0.54 billion in 2023 to $1.07 billion by 2033, driven by rising healthcare investments and increasing patient awareness about TPE.Request a custom research report for industry.
Therapeutic Plasma Exchange Market Analysis By Indication
Global Therapeutic Plasma Exchange Market, By Indication Market Analysis (2023 - 2033)
The Therapeutic Plasma Exchange market is significantly influenced by its applications in various diseases. Neurological disorders hold the largest market share, accounting for $3.61 billion in 2023 and expected to reach $7.09 billion by 2033. Hematological disorders and autoimmune disorders follow with respective shares of $1.33 billion and $0.67 billion and estimated growth to $2.61 billion and $1.31 billion by 2033.
Therapeutic Plasma Exchange Market Analysis By Equipment
Global Therapeutic Plasma Exchange Market, By Equipment Market Analysis (2023 - 2033)
In terms of equipment, apheresis devices dominate the market with significant demand, valued at $4.79 billion in 2023, projected to grow to $9.41 billion by 2033. Accessories also contribute, growing from $0.81 billion to $1.59 billion in the same period, reflecting an overall demand for complete plasma exchange solutions.
Therapeutic Plasma Exchange Market Analysis By Therapy Type
Global Therapeutic Plasma Exchange Market, By Therapy Type Market Analysis (2023 - 2033)
Market analysis by therapy type indicates that standard plasmapheresis accounts for the majority share, supported by its widespread application, while dual-filtration plasmapheresis holds considerable potential due to its benefits in efficiency and efficacy.
Therapeutic Plasma Exchange Market Analysis By End User
Global Therapeutic Plasma Exchange Market, By End-User Market Analysis (2023 - 2033)
Hospitals are the primary end-users of TPE services, commanding a market share of $3.61 billion in 2023 with a steady growth trajectory to $7.09 billion by 2033. Blood banks and specialized clinics also play vital roles in service provision and market dynamics.
Therapeutic Plasma Exchange Market Analysis By Region Usage
Global Therapeutic Plasma Exchange Market, By Region Usage Market Analysis (2023 - 2033)
Regional analysis of TPE indicates that North America and Europe are currently the largest markets, driven by technological advancements and higher healthcare spending. The Asia Pacific region shows strong growth potential due to expanding healthcare services and increasing patient population.
Therapeutic Plasma Exchange Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Therapeutic Plasma Exchange Industry
Terumo BCT:
A leading provider of blood component collection and cellular therapies, Terumo BCT specializes in apheresis devices that enhance the effectiveness of Therapeutic Plasma Exchange.Fresenius Kabi:
Fresenius Kabi is recognized for its development of innovative infusion and transfusion technology, including advanced apheresis systems, contributing significantly to the TPE market.Haemonetics Corporation:
Haemonetics focuses on blood management solutions and has carved a niche in the plasma exchange market with its comprehensive product offerings.Grifols:
Grifols is a major player in the biopharmaceutical industry and is heavily involved in plasma-derived therapies, including TPE solutions, reinforcing its position in the market.We're grateful to work with incredible clients.
